Abstract

α-Melanocyte-stimulating hormone (α-MSH, α-melanotropin), [Nle 4,D-Phe 7]-α-MSH and related fragment analogues, Ac-[Nle 4,D-Phe 7]-α-MSH 4–11-NH 2 and Ac-[Nle 4,D-Phe 7]-α-MSH 4–10-NH 2, were studied for their ability to stimulate tyrosinase activity in Cloudman S91 mouse melanoma cells in tissue culture. All of the melanotropins stimulated tyrosinase activity in a dose-dependent manner. [Nle 4,D-Phe 7]-α-MSH was about 100 times more active than a-MSH as determined from the minimal effective dose (MED) required to activate the enzyme above control (basal) levels. The MED of this analogue to significantly stimulate tyrosinase activity at 24, 48 and 72 h of incubation was 10 −11 M whereas the MED of α-MSH was 10 −9 M at each of these times. The maximum tyrosinase activity achieved from the time of initial incubation in the presence of [Nle 4,D-Phe 7]-α-MSH was approximately 3-, 5- and 6-fold greater than control levels at 24, 48 and 72 h, respectively. The 2 [Nle 4,D-Phe 7]-substituted fragment analogues were at least as active as the tridecapeptide analogue and therefore at least 100-fold more active than a-MSH in stimulating enzyme activity. These [Nle 4,D-Phe 7]-substituted analogues were more active in the melanoma tyrosinase assay than in the melanoma adenylate cyclase assay or other normal melanocyte (frog and lizard skin) bioassays.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.